Biochem. Biophy. Res. Commun.
| [0004]
|
a randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
| [0007]
|
Bone mineralization and regulation of phosphate homeostasis
| [0025]
|
American Journal of Physiology - Endocrinology and Metabolism
| [0025]
|
Evidence for Fgf23 Involvement in a Bone - Kidney Axis Regulating Bone Mineralization and Systemic Phosphate and Vitamin D Homeostasis
| [0025]
|
Sequences of Proteins of Immunological Interest
| [0034]
|
Applications and Engineering of Monoclonal Antibodies
| [0047]
|
Computational Molecular Biology
| [0053]
|
Biocomputing Informatics and Genome Projects
| [0053]
|
Computer Analysis of Sequence Data
| [0053]
|
Sequence Analysis in Molecular Biology
| [0053]
|
Sequence Analysis Primer
| [0053]
|
SIAM I Applied Math.
| [0053]
|
Nucl. Acid Res.
| [0054]
|
Atlas of Protein Sequence and Structure
| [0054]
|
Proc. Natl. Acad. Sci. U.S.A.
| [0054]
|
J. Mol. Biol.
| [0055]
|
Ann Intern Med.
| [0065]
|
The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis of congenital hypophosphatemia
| [0067]
|
Pediatric reference intervals for 19 biologic variables in healthy children
| [0067]
|
Autosomal Dominant Hypophosphataemic Rickets is Associated with Mutations in FGF23
| [0069]
|
Effect of Fibroblast Growth Factor-23 on Phosphate Transport in Proximal Tubules
| [0069]
|
Fibroblast Growth Factor 23 Impairs Phosphorus and Vitamin D Metabolism In Vivo and Suppresses 25-hydroxyvitamin D-lalpha-hydroxylase Expression In Vitro
| [0069]
|
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
| [0069]
|
Molecular Insights into the Klotho-dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members
| [0069]
|
FGFR3 and FGFR4 do not Mediate Renal Effects of FGF23
| [0069]
|
FGF23 Decreases Renal NaPi-2a and NaPi-2c Expression and Induces Hypophosphatemia in vivo Predominantly via FGF Receptor 1
| [0069]
|
Mutation of the Mouse Klotho Gene Leads to a Syndrome Resembling Aging
| [0069]
|
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
| [0069]
[0069]
|
Klotho Converts Canonical FGF Receptor into a Specific Receptor for FGF23
| [0069]
[0069]
|
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
| [0069]
|
Molecular Insights into the Klotho-dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members
| [0069]
|
Klotho converts canonical FGF receptor into a specific receptor for FGF23
| [0069]
|
Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia
| [0069]
|
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
| [0070]
|
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
| [0070]
|
1alpha, 25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport
| [0070]
|
Novel regulators of Fgf23 expression and mineralization in Hyp bone
| [0070]
|
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
| [0070]
|
Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein
| [0071]
|
Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane
| [0071]
|
Suppression of aging in mice by the hormone Klotho
| [0071]
|
Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein
| [0071]
|
Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein
| [0071]
|
The Complete Amino Acid Sequence of the Shorter Form of Human Basic Fibroblast Growth Factor Receptor Deduced from its cDNA
| [0072]
|
Kallmann Syndrome: Fibroblast Growth Factor Signaling Insufficiency?
| [0072]
|
Roles of FGF Receptors in Mammalian Development and Congenital Diseases
| [0072]
|
BioDrugs
| [0074]
|
J. Biol. Chem.
| [0074]
|
Proc. Natl. Acad. Sci. USA
| [0074]
|
J. Cell Physiol.
| [0074]
|
Severe hypophosphatemia in postoperative patients
| [0076]
|
Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets
| [0076]
|
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
| [0078]
|
Methods in Protein Biochemistry
| [0089]
|
Chip-based detection of protein cancer markers
| [0089]
|
Proteome Analysis: Interpreting the Genome
| [0089]
|
Protein Arrays, Biochips and Proteomics
| [0089]
|
The Protein Protocols Handbook
| [0089]
|
Protein Arrays: Methods and Protocols
| [0089]
|
Acceleration and Improvement of Protein Identification by Mass Spectrometry
| [0089]
|
Current Protocols in Molecular Biology
| [0089]
|
Current Protocols in Protein Science Last
| [0089]
|
Current Protocols in Nucleic Acid Chemistry
| [0089]
|
Current Protocols in Bioinformatics
| [0089]
|
Molecular Cloning: A Laboratory Manual
| [0089]
|
Methods Enzymol.
| [0100]
|
Nature Rev. Genetics
| [0100]
|
Cell
| [0100]
|
Curr. Biol.
| [0100]
|
20
| [0100]
|
Chembiochem
| [0100]
|
Cell Sci.
| [0100]
|
EMBO J.
| [0100]
|
Science
| [0100]
|
Nature
| [0100]
|
J. Biomed. Mater. Res.
| [0112]
|
Chem. Tech.
| [0112]
|
Biopolymers
| [0112]
|
CRC Crit. Ref. Biomed. Eng.
| [0112]
|
Surgery
| [0112]
|
N. Engl. J. Med.
| [0112]
|
Medical Applications of Controlled Release
| [0112]
|
Science
| [0112]
|
Remington: The Science and Practice of Pharmacy'' (formerly ''Remingtons Pharmaceutical Sciences)
| [0117]
|
Ann Clin Biochem
| [0134]
|
Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia
| [0278]
|